Literature DB >> 28557775

Nonemergency Acute Care: When It's Not the Medical Home.

Gregory P Conners, Susan J Kressly, James M Perrin, Julia E Richerson, Usha M Sankrithi.   

Abstract

The American Academy of Pediatrics (AAP) affirms that the optimal location for children to receive care for acute, nonemergency health concerns is the medical home. The medical home is characterized by the AAP as a care model that "must be accessible, family centered, continuous, comprehensive, coordinated, compassionate, and culturally effective." However, some children and families use acute care services outside the medical home because there is a perceived or real benefit related to accessibility, convenience, or cost of care. Examples of such acute care entities include urgent care facilities, retail-based clinics, and commercial telemedicine services. Children deserve high-quality, appropriate, and safe acute care services wherever they access the health care system, with timely and complete communication with the medical home, to ensure coordinated and continuous care. Treatment of children under established, new, and evolving practice arrangements in acute care entities should adhere to the core principles of continuity of care and communication, best practices within a defined scope of services, pediatric-trained staff, safe transitions of care, and continuous improvement. In support of the medical home, the AAP urges stakeholders, including payers, to avoid any incentives (eg, reduced copays) that encourage visits to external entities for acute issues as a preference over the medical home.
Copyright © 2017 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2017        PMID: 28557775     DOI: 10.1542/peds.2017-0629

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

1.  Antibiotic Prescribing During Pediatric Direct-to-Consumer Telemedicine Visits.

Authors:  Kristin N Ray; Zhuo Shi; Courtney A Gidengil; Sabrina J Poon; Lori Uscher-Pines; Ateev Mehrotra
Journal:  Pediatrics       Date:  2019-04-08       Impact factor: 7.124

2.  Use of Commercial Direct-to-Consumer Telemedicine by Children.

Authors:  Kristin N Ray; Zhuo Shi; Sabrina J Poon; Lori Uscher-Pines; Ateev Mehrotra
Journal:  Acad Pediatr       Date:  2019-01-10       Impact factor: 3.107

3.  Patterns of Primary, Specialty, Urgent Care, and Emergency Department Care in Children With Inflammatory Bowel Diseases.

Authors:  Hilary K Michel; Robert B Noll; Nalyn Siripong; Sandra C Kim
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-07       Impact factor: 2.839

4.  Remote Versus In-person Outpatient Clinic Visits and Antibiotic Use Among Children During the COVID-19 Pandemic.

Authors:  Dana Danino; Shalom Ben-Shimol; Amir Sharf; David Greenberg; Noga Givon-Lavi
Journal:  Pediatr Infect Dis J       Date:  2022-07-13       Impact factor: 3.806

Review 5.  Remote Monitoring of Patient- and Family-Generated Health Data in Pediatrics.

Authors:  Carolyn Foster; Dana Schinasi; Kristin Kan; Michelle Macy; Derek Wheeler; Allison Curfman
Journal:  Pediatrics       Date:  2022-02-01       Impact factor: 9.703

6.  Comparison of a Novel Handheld Telehealth Device with Stand-Alone Examination Tools in a Clinic Setting.

Authors:  Nancy L McDaniel; Wendy Novicoff; Brian Gunnell; David Cattell Gordon
Journal:  Telemed J E Health       Date:  2018-12-18       Impact factor: 3.536

7.  Effect of Population Lockdown on Pediatric Emergency Room Demands in the Era of COVID-19.

Authors:  Francesco Valitutti; Letizia Zenzeri; Angela Mauro; Rosario Pacifico; Micaela Borrelli; Stefania Muzzica; Giovanni Boccia; Vincenzo Tipo; Pietro Vajro
Journal:  Front Pediatr       Date:  2020-09-18       Impact factor: 3.418

8.  A Pediatric Telemedicine Research Agenda: Another Important Task for Pediatric Chairs.

Authors:  Alexander G Fiks; Mary Kate Kelly; Uchenna Nwokeji; Janani Ramachandran; Kristin N Ray; David Gozal
Journal:  J Pediatr       Date:  2022-08-06       Impact factor: 6.314

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.